What Pharma Needs Next

The Enablers of Medical Impact in the Age of AI

Michael Hamann and Andreas Gerloff join Christoph Bug to examine key enablers of medical impact. Discover how MSD and Daiichi Sankyo Europe use AI to analyze MSL insights

AI-Driven Insights through Connected Data and Software

In this episode, Stefan Schmidt and Florian Schnappauf discuss key technology shifts from Cloud to AI, and the accelerated pace of commercial innovation. Explore how Baye

Architecting the AI-Ready Enterprise

In this episode, Kieron Scrutton joins Florian Schnappauf to discuss architecting an AI-ready enterprise to achieve commercial efficiency at scale. Discover why prioritiz

UCB and Takeda: Improving the Customer Experience through Medical-Commercial Collaboration

What happens when medical and commercial teams truly align? Stronger launches, a smoother HCP experience, and better patient outcomes. In this episode, Christoph Bug spea

Turning Content into Memorable Customer Experiences

How does great content become memorable customer experiences in life sciences? Erica Taylor and Oz Demir of Genentech share their recent experiences of spearheading marke

Preparing for a Faster Trial-to-Treatment Pathway

Pharmaphorum’s Nicole Raleigh interviews Chris Moore, president of Veeva Europe, on trends shaping commercial life sciences. Chris highlights AI’s potential use cases, th

Preparing for a Launch: Pharma's High-Stakes Gamble

Veeva's Florian Schnappauf speaks to Andy Eeckhout of ADVANZ PHARMA about ensuring launch success. Preparing for a launch is a high-stakes gamble for all biopharma compan

The Problem of Plenty in Life Sciences

Despite major advances in recent years, it is still too difficult for biopharma field teams to bring together all relevant information to serve HCPs. Florian Schnappauf a

Navigating the New Medical Affairs Landscape: Data, Impact, and the Evolving MSL Role

In this episode, Christoph Bug, VP Global Medical at Veeva, discusses the evolving role of medical affairs with industry experts. They explore how medical teams adapt to